White bears test green light for Chinese novel coronavirus vaccine Ad5-nCoV in Russia
On December 7, the news agency Interfax reported that Russian authorities allow clinical trials of the vaccine, Ad5-nCoV, a virus that prevents COVID-19. Developed by Cancino Biologics and the China Military Research Center in Russia. A Chinese clinical trial of this vaccine in Russia will involve 8,000 volunteers in the trial, however detailed information on this matter is not yet available.
